A 2022 article articulated this notion succinctly by declaring "During the business of drug development, specials could be equally as important as scientific breakthroughs", commonly known as pharmaceutical M&A (for mergers and acquisitions). drugs to try to remain sane. From TIME The insurer says It is really overpaying for pharmaceuticals https://remingtondhmqu.tnpwiki.com/6284936/what_does_chemical_intellectual_property_support_mean